PET imaging of reactive astrocytes in neurological disorders

Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1275-1287. doi: 10.1007/s00259-021-05640-5. Epub 2021 Dec 7.

Abstract

The reactive astrocytes manifest molecular, structural, and functional remodeling in injury, infection, or diseases of the CNS, which play a critical role in the pathological mechanism of neurological diseases. A growing need exists for dependable approach to better characterize the activation of astrocyte in vivo. As an advanced molecular imaging technology, positron emission tomography (PET) has the potential for visualizing biological activities at the cellular levels. In the review, we summarized the PET visualization strategies for reactive astrocytes and discussed the applications of astrocyte PET imaging in neurological diseases. Future studies are needed to pay more attention to the development of specific imaging agents for astrocytes and further improve our exploration of reactive astrocytes in various diseases.

Keywords: Alzheimer’s disease (AD); Amyotrophic lateral sclerosis (ALS); Monoamine oxidases-B (MAO-B); Multiple sclerosis (MS); Parkinson’s disease (PD); Positron emission tomography (PET); Reactive astrocytes.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / pathology
  • Astrocytes / pathology
  • Humans
  • Nervous System Diseases* / diagnostic imaging
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed